Histone deacetylase 6 — Drug Target

All drugs that target Histone deacetylase 6 — marketed and clinical-stage. Includes 3 drug classes acting on this target.

Drug classes

Alkylating Drug · Histone Deacetylase Inhibitor [EPC] · Anthracycline Topoisomerase Inhibitor

Marketed (3)

• Treanda · Baxter · Alkylating Drug · Oncology
  Treanda works by attaching an alkyl group to the DNA of cancer cells, interfering with their ability to replicate and grow.
• Zolinza · Merck & Co. · Histone Deacetylase Inhibitor [EPC] · Oncology
  Zolinza works by blocking the action of histone deacetylase 6, an enzyme that removes acetyl groups from histones, leading to changes in gene expression.
• Daunorubicin Hydrochloride · Meiji Seika Pharma Co., Ltd · Anthracycline Topoisomerase Inhibitor · Oncology